The Effect of Oxcarbazepine on the Pharmacokinetics of Single-Dose Aripiprazole in a Rat Model
Medicines · 01.04.2026 · 13 (2) · 13
DOI: 10.3390/medicines13020013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicines, online erschienen am 01.04.2026. Verfasst von Iulia-Maria Ciocotișan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology and Biopharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, Victor Babeș Street 41, 400012 Cluj-N…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Iuliu Hatieganu” University of Medicine and Pharmacy.
Abstract (Originalsprache)
Background/Objectives: A possible pharmacokinetic interaction between a single dose of aripiprazole and multiple-dose pretreatment with oxcarbazepine was investigated in vivo in Wistar albino rats.
Methods
The experiment was conducted on two groups of 12 male rats each. The control group received a single oral dose of aripiprazole (8 mg/kg), while the test group was given oral oxcarbazepine (85 mg/kg/day) for 5 days, followed by a single oral dose of aripiprazole (8 mg/kg). Blood samples were automatically drawn following the administration of aripiprazole to each rat. Noncompartmental analysis was employed to determine the pharmacokinetic parameters of aripiprazole and its active metabolite, dehydroaripiprazole.
Results
After the five-day oxcarbazepine pretreatment, aripiprazole’s maximum plasma concentration decreased by 51.37%, and its mean half-life was significantly reduced by 1.51-fold. In contrast, for the metabolite, the mean total area under the concentration–time curve increased by 44.66%, and the mean apparent systemic clearance decreased by 61.84%.
Conclusions
Multiple-dose pretreatment with oxcarbazepine resulted in significant changes in the pharmacokinetics of a single oral dose of aripiprazole and its active metabolite in vivo in rats. The clinical implications should be further studied in human subjects, as this interaction may reduce the efficacy of aripiprazole.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology and Biopharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, Victor Babeș Street 41, 400012 Cluj-Napoca, Romania.
ORCID-Profile: Iulia-Maria Ciocotișan, Dana Maria Muntean, Laurian Vlase
Förderung
- "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania
- Iuliu Hatieganu” University of Medicine and Pharmacy
Zitieren
APA
Ciocotișan, I. M., Muntean, D. M., & Vlase, L. (2026). The Effect of Oxcarbazepine on the Pharmacokinetics of Single-Dose Aripiprazole in a Rat Model. Medicines, 13(2), 13. https://doi.org/10.3390/medicines13020013
Vancouver
Ciocotișan IM, Muntean DM, Vlase L. The Effect of Oxcarbazepine on the Pharmacokinetics of Single-Dose Aripiprazole in a Rat Model. Medicines. 2026;13(2):13. doi:10.3390/medicines13020013
BibTeX
@article{Ciocotian2026,
author = {Ciocotișan, Iulia-Maria and Muntean, Dana Maria and Vlase, Laurian},
title = {The Effect of Oxcarbazepine on the Pharmacokinetics of Single-Dose Aripiprazole in a Rat Model},
journal = {Medicines},
year = {2026},
volume = {13},
number = {2},
pages = {13},
doi = {10.3390/medicines13020013}
}
EUVIMED